Literature DB >> 11733902

Effect of bilirubin in ischemia/reperfusion injury on rat small intestine.

C Ceran1, K Sönmez, Z Türkyllmaz, B Demirogullarl, A Dursun, E Düzgün, A C Başaklar, N Kale.   

Abstract

PURPOSE: The aim of this study was to determine the effects of bilirubin in experimental small intestinal ischemia/reperfusion (I/R) injury in rats.
METHODS: Thirty rats were divided into 5 groups (n = 6). In group S, saline and in group B, bilirubin, 20 mg/kg were infused via the jugular vein without an additional procedure. In groups S-IR, saline, B(1)-IR and B(2)-IR, 10 and 20 mg/kg/h of bilirubin were infused for 2 hours, respectively. In these groups, an I/R procedure was done after infusions by occluding the superior mesenteric artery for 45 minutes followed by 1 hour of reperfusion. After reperfusion, the small intestines were resected for histopathologic and malondialdehyde (MDA) assessments. Mucosal lesions were scored between 0 and 5. Malondialdehyde levels and histopathologic grades were analyzed statistically.
RESULTS: Mucosal injury was severe in S-IR (grade 4 to 5), mild in B(1)-IR (grade 0 to 3) and none in B(2)-IR group (grade 0). Grades of group S-IR were higher than those of B(1)-IR and B(2)-IR statistically (P <.05). Tissue MDA levels of the S-IR group were significantly higher than those of B(1)-IR and B(2)-IR groups (U = 36, P <.05). Bilirubin levels correlated inversely with MDA levels (r = -0.94).
CONCLUSIONS: Bilirubin effectively prevents intestinal I/R injury in rat. This observation is consistent with the hypotheses regarding bilirubin as an antioxidant, having a role in the body defense. J Pediatr Surg 36:1764-1767. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733902     DOI: 10.1053/jpsu.2001.28816

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Preservation solution supplemented with biliverdin prevents lung cold ischaemia/reperfusion injury.

Authors:  Ryujiro Sugimoto; Yugo Tanaka; Kentaro Noda; Tomohiro Kawamura; Yoshiya Toyoda; Timothy R Billiar; Kenneth R McCurry; Atsunori Nakao
Journal:  Eur J Cardiothorac Surg       Date:  2012-05-30       Impact factor: 4.191

Review 2.  Heme oxygenase-1 and gut ischemia/reperfusion injury: A short review.

Authors:  Yu-Feng Liao; Wei Zhu; Dong-Pei Li; Xiao Zhu
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

3.  Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration.

Authors:  A C Bulmer; J S Coombes; J T Blanchfield; I Toth; R G Fassett; S M Taylor
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

4.  Increased antioxidant capacity of serum did not prevent lipid peroxidation in the intermittent ischemia-reperfusion of rat small intestine.

Authors:  Hana Cizova; Ivana Papezikova; Lukas Kubala; Antonin Lojek; Milan Ciz
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

Review 5.  Heme Oxygenase 1 in Vertebrates: Friend and Foe.

Authors:  Rafael Cardoso Maciel Costa Silva; Leonardo Holanda Travassos Correa
Journal:  Cell Biochem Biophys       Date:  2021-11-20       Impact factor: 2.194

Review 6.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1.

Authors:  HongSeob So; HyungJin Kim; Yunha Kim; Eunsook Kim; Hyun-Ock Pae; Hun-Taeg Chung; Hye-Jung Kim; Kang-Beom Kwon; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2008-06-27

8.  Effects of trapidil on intestinal mucosal barrier function and bacterial translocation after intestinal ischemia and reperfusion in an experimental rat model.

Authors:  Tahsin Colak; Candan Ozturk; Ayse Polat; Ozlen Bagdatoglu; Arzu Kanik; Ozgur Turkmenoglu; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2003-06

Review 9.  CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation.

Authors:  D Babu; R Motterlini; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

10.  Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury.

Authors:  Atsunori Nakao; David J Kaczorowski; Ryujiro Sugimoto; Timothy R Billiar; Kenneth R McCurry
Journal:  J Clin Biochem Nutr       Date:  2008-03       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.